Mr. Damien McCallion:

The challenge we face is finding capacity. Until we get sufficient capacity, we will not be able to diminish the waiting list. We need laboratory capacity to carry out the testing. That capacity is severely constrained within our three existing providers and internationally because laboratories and countries are moving to HPV testing, which brings about significant challenges because cytology is being reduced and laboratories in implementation mode are not in a position to provide services to us. We have carried out a global trawl for providers who could beef up our capacity. If we expand capacity sufficiently, we will be able to catch up on the curve. It is a battle to get ahead of the curve but we are considering all possible sources, public and private, here and internationally to do so.